799 results on '"Knobler, Robert"'
Search Results
2. Primary Cutaneous Lymphomas
3. EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2023
4. Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC
5. Consensus statement on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxoedema and scleroedema.
6. Resminostat for Maintenance Treatment in Patients with Advanced Stage Mycosis Fungoides or Sézary Syndrome: A Multicentre, Double-Blind, Randomised, Placebo-Controlled, Phase 2 Trial
7. Wirkweise, Indikationen und Therapieempfehlungen der extrakorporalen Photopherese (ECP)
8. Mode of action, indications and recommendations on extracorporeal photopheresis (ECP)
9. RESMAIN: results of a multicenter, randomized, double blind, placebocontrolled trial to evaluate resminostat for maintenance treatment in advanced stage mycosis fungoides or Sézary syndrome
10. Blood classification and blood response criteria in mycosis fungoides and Sézary syndrome using flow cytometry: recommendations from the EORTC cutaneous lymphoma task force
11. A potassium-titanyl-phosphate laser is an efficacious tool in the treatment of pyogenic granulomas. A retrospective study in 28 patients
12. Faculty Opinions recommendation of Ultraviolet exposure regulates skin metabolome based on the microbiome.
13. Faculty Opinions recommendation of Allogeneic transplantation in advanced cutaneous T-cell lymphomas (CUTALLO): a propensity score matched controlled prospective study.
14. European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2017
15. Primary Cutaneous Lymphomas
16. Faculty Opinions recommendation of Identifying highly active anti-CCR4-CAR T cells for the treatment of T-cell lymphoma.
17. Faculty Opinions recommendation of Blockade of the Immune Checkpoint CD47 by TTI-621 Potentiates the Response to Anti-PD-L1 in Cutaneous T Cell Lymphoma.
18. Extracorporeal photopheresis as an immunomodulatory treatment modality for chronic GvHD and the importance of emerging biomarkers
19. O-143 - RESMAIN: results of a multicenter, randomized, double blind, placebocontrolled trial to evaluate resminostat for maintenance treatment in advanced stage mycosis fungoides or Sézary syndrome
20. Identifying unmet needs and challenges in the definition of a plaque in mycosis fungoides: An EORTC‐CLTG/ISCL survey
21. Faculty Opinions recommendation of Quality of Life in Cutaneous T-cell Lymphoma Patients Receiving Mogamulizumab: Important Factors to Consider.
22. Prophylactic Extracorporeal Photopheresis to Prevent Acute Rejection after Lung Transplantation: A Prospective Randomized Controlled Trial
23. Faculty Opinions recommendation of In vivo modelling of cutaneous T-cell lymphoma: The role of SOCS1.
24. Faculty Opinions recommendation of Targeting the CD47-SIRPα Axis: Present Therapies and the Future for Cutaneous T-cell Lymphoma.
25. Cutaneous Graft-Versus-Host Disease: Diagnosis and Treatment
26. A phase III study of lenalidomide maintenance after debulking therapy in patients with advanced cutaneous T-cell lymphoma - EORTC 21081 (NCT01098656): results and lessons learned for future trial designs
27. Sezary Syndrome
28. Faculty Opinions recommendation of Cutaneous T-cell lymphomas: 2023 update on diagnosis, risk-stratification, and management.
29. Faculty Opinions recommendation of Malignant T cells induce skin barrier defects through cytokine-mediated JAK/STAT signalling in cutaneous T-cell lymphoma.
30. Faculty Opinions recommendation of BRENTUXIMAB VEDOTIN IN THE TREATMENT OF CUTANEOUS T-CELL LYMPHOMAS: data from the Spanish Primary Cutaneous Lymphoma Registry.
31. Faculty Opinions recommendation of Impact of blood involvement on efficacy and time to response with mogamulizumab in mycosis fungoides and Sézary syndrome.
32. Faculty Opinions recommendation of Integrated transcriptome and trajectory analysis of cutaneous T-cell lymphoma identifies putative precancer populations.
33. Graft-Versus-Host Disease
34. Extracorporeal photopheresis in acute and chronic graft-versus-host disease
35. ECP and solid organ transplantation
36. Diverse T-cell responses characterize the different manifestations of cutaneous graft-versus-host disease
37. Extracorporeal Photoimmunochemotherapy
38. Extracorporeal Photopheresis (ECP) and Calcineurin Inhibitor (CNI) delay after Heart Transplantation
39. Light Treatment in Medicine
40. Faculty Opinions recommendation of Cutaneous Lymphocyte Antigen (CLA) is a potential therapeutic target in Cutaneous T Cell Lymphoma.
41. Faculty Opinions recommendation of Characterization of primary cutaneous T-cell lymphoma following solid organ transplantation.
42. Faculty Opinions recommendation of Genetically driven CD39 expression affects Sezary cell viability, IL-2 production and detects two patient subsets with distinct prognosis.
43. Extracorporeal Photoimmunochemotherapy
44. Major achievements of the EORTC Cutaneous Lymphoma Task Force (CLTF)
45. Faculty Opinions recommendation of PLCγ1/PKCθ Downstream Signaling Controls Cutaneous T-Cell Lymphoma Development and Progression.
46. Faculty Opinions recommendation of Resistance to mogamulizumab is associated with loss of CCR4 in Cutaneous T-cell Lymphoma.
47. Faculty Opinions recommendation of IL-32 supports the survival of malignant T cells in cutaneous T cell lymphoma.
48. Faculty Opinions recommendation of Downregulation of miR-26 promotes invasion and metastasis via targeting interleukin-22 in cutaneous T-cell lymphoma.
49. Extracorporeal Photopheresis With Low-Dose Immunosuppression in High-Risk Heart Transplant Patients—A Pilot Study
50. Faculty Opinions recommendation of Service improvement in a nurse-led clinic for extracorporeal photopheresis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.